By Distribution Channel

Hospital Direct (GPO-Negotiated) Market Analysis

Cross-industry research covering Hospital Direct (GPO-Negotiated) across 1 market reportspanning Pharmaceuticals.

1 Reports

1 Industries

Reports Covering Hospital Direct (GPO-Negotiated)

Dysautonomia Treatment Drugs Market to Reach USD 8.4 Billion by 2033 at 7.2% CAGR

Pharmaceuticals·Market: USD 4.8 Billion (2025)·CAGR: 7.2%

Hospital drug purchasing through GPO agreements governs IV formulations and inpatient autonomic agent procurement; 340B pricing for qualifying facilities further reduces manufacturer net revenue in this channel.

14%

Market Share

6.5%

Segment CAGR

Explore More Segments

Browse all market segments across our research coverage.

View all segments